INVO BioScience shares are trading higher after the company reported a year-over-year increase in Q4 revenue results and said it remains on track to reach its goal of reaching break-even or profitability within its current operations in 2024.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.